wellrank.ai

How much is Ozempic per month without insurance and how do people afford it?

ClaudepricingCollected Jun 22, 2026, 09:37 UTC

Verbatim response from Claude

Ozempic Cost Without Insurance

Typical retail price: $900–$1,000+ per month for a monthly supply (the 0.5mg or 1mg dose pens).


How People Afford It

Manufacturer Savings:

  • Novo Nordisk's savings card – Eligible commercially insured patients may pay as little as $25/month, but this doesn't help uninsured people much

Compounding Pharmacies (Most Popular Workaround):

  • Hims & Hers, Ro, LifeMD offer compounded semaglutide (same active ingredient) for roughly $150–$300/month
  • Note: The FDA has raised safety concerns about compounded versions, so discuss with your doctor

Discount Programs:

  • GoodRx – Can reduce cost to ~$850–$950, so modest savings
  • NovoCare Patient Assistance Program – Free medication for qualifying low-income patients (novo nordisk.com)

International Pharmacies:

  • Some people order from Canadian pharmacies at significantly lower prices, though this has legal gray areas

Insurance Navigation:

  • Getting a diagnosis of Type 2 diabetes (vs. just obesity) dramatically improves coverage odds
  • Switching to Wegovy (same drug, FDA-approved for weight loss) may have better coverage under some plans

Bottom line: The compounding pharmacy route is currently how most uninsured people manage costs, though verify safety with your doctor.

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.